|
|
Effects of Edaravone on AT1R/StAR/MR signaling pathway in myocardial remodeling mice |
XUE Yangyang1 QIN Yaoyao1 GAO Jianhui1 YUE Luanyi2 ZHANG Weiwei3 YU Shuzhen3 |
1.College of Anesthesia, Shanxi Medical University, Shanxi Province, Taiyuan 030001, China;
2.the Fifth Clinical Medical College, Shanxi Medical University, Shanxi Province, Taiyuan 030001, China;
3.Department of Anesthesiology, the Shanxi Medical University Affiliated People’s Hospital, Shanxi Province, Taiyuan 030012, China
|
|
|
Abstract Objective To explore the relationship between angiotensin Ⅱ type 1 receptor (AT1R)/ steroidogenic acute regulatory protein (StAR)/ mineralocorticoid receptor (MR) and myocardial remodeling induced by pressure overload in mice treated with Edaravone. Methods Eighteen SPF grade C57 mice, aged four weeks and weighing 22-24 g, were divided into control group, angiotensin Ⅱ group, and Edaravone group according to random number table method, with six mice in each group. The mouse myocardial remodeling model was prepared by continuous infusion of angiotensin Ⅱ 1 500 ng/(kg·min) with a subcutaneous osmotic pump for 28 days. The control group was implanted with an osmotic pump pre-filled with 0.9% sodium chloride; the edaravone group was given intraperitoneal injection of 10 mg/kg of Edaravone per day for 28 days after subcutaneous implantation of a prefilled angiotensin Ⅱ osmotic pump. After the model was successfully prepared, the hearts of mice were sacrificed and weighed to calculate the ratio of heart weight to body weight (HW/BW). Paraffin sections of myocardium were taken, and the cross-sectional area of cardiomyocytes was determined by hematoxylin-eosin staining, and collagen volume fraction was determined by Masson’s staining. The expressions of angiotensin type 1 receptor (AT1R), steroid-synthesized acute regulatory protein (StAR), salocorticoid receptor (MR), transforming growth factor-β1(TGF-β1) and α-smooth muscle actin (α-SMA) in cardiomyocytes were determined by immunohistochemical staining. Results The HW/BW ratio, MSA and CVF in angiotensin Ⅱ group were higher than those in control group, and the differences were statistically significant (P<0.05). The HW/BW ratio, MSA, and CVF in Edaravone group were lower than those in angiotensin Ⅱ group, and the differences were statistically significant (P<0.05). The protein expressions of AT1R, StAR, TGF-β1, α-SMA, and MR in angiotensin Ⅱ group were higher than those in control group, and the differences were statistically significant (P<0.05). The protein expressions of AT1R, StAR, TGF-β1, α-SMA, and MR in Edaravone group were lower than those in angiotensin Ⅱ group, and the differences were statistically significant (P<0.05). Conclusion The myocardial remodeling induced by pressure overload in mice treated with Edaravone is related to the inhibition of AT1R /StAR/MR.
|
|
|
|
|
[1] Benjamin EJ,Muntner P,Alonso A,et al. Heart Disease and Stroke Statistics-2019 Update:A Report From the American Heart Association [J]. Circulation,2019,139(10):e56-e528.
[2] 《中国心血管健康与疾病报告2020》正式出版[J].中国心血管杂志,2021,26(3):276.
[3] Braunwald E. The war against heart failure:the Lancet lecture [J]. Lancet,2015,385(9970):812-824.
[4] Bektik E,Fu JD. Ameliorating the Fibrotic Remodeling of the Heart through Direct Cardiac Reprogramming [J]. Cells,2019, 8(7):679.
[5] Mcdonagh TA,Metra M,Adamo M,et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure:Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC [J]. Rev Esp Cardiol (Engl Ed),2022,75(6):523.
[6] 刘晓萍,赖香茂,欧阳资章,等.依普利酮对血管紧张素Ⅱ诱导心脏成纤维细胞增殖的影响[J].中国医院药学杂志,2021,41(7):700-704.
[7] 汪羚利,李昭屏.盐皮质激素受体拮抗剂在难治性高血压中的应用现状[J].心血管病学进展,2020,41(10):1026-1030.
[8] Shakkour Z,Issa H,Ismail H,et al. Drug Repurposing:Promises of Edaravone Target Drug in Traumatic Brain Injury [J]. Curr Med Chem,2021,28(12):2369-2391.
[9] Kikuchi K,Miura N,Kawahara KI,et al. Edaravone (Radicut),a free radical scavenger,is a potentially useful addition to thrombolytic therapy in patients with acute ischemic stroke [J]. Biomed Rep,2013,1(1):7-12.
[10] 王娟,顾顺忠,陆洋,等.依达拉奉改善大鼠心肌缺血损伤和炎症反应[J].中南医学科学杂志,2022,50(4):495-498.
[11] 苏天生,卢静,肖章武,等.参附注射液结合依达拉奉对心肌缺血再灌注损伤治疗效果的影响分析[J].中外医学研究,2022,20(25):165-169.
[12] Zhang W,Guo Y,Yu S,et al. Effects of edaravone on the expression of beta-defensin-2 mRNA in lung tissue of rats with myocardial ischemia reperfusion [J]. Mol Med Rep,2013, 7(5):1683-1687.
[13] Zhang WW,Bai F,Wang J,et al. Edaravone inhibits pressure overload-induced cardiac fibrosis and dysfunction by reducing expression of angiotensin II AT1 receptor [J]. Drug Des Devel Ther,2017,11:3019-3033.
[14] 张玮玮,余淑珍,郑李娜,等.依达拉奉抑制大鼠压力超负荷致心肌重构形成与AT1R/MAPKs/StAR信号通路的关系[J].中华麻醉学杂志,2021,41(5):625-629.
[15] Zhang WW,Zheng RH,Bai F,et al. Steroidogenic acute regulatory protein/aldosterone synthase mediates angiotensin Ⅱ-induced cardiac fibrosis and hypertrophy [J]. Mol Biol Rep,2020,47(2):1207-1222.
[16] 于敏,姜君财,骆妍蓓,等.血管紧张素Ⅱ诱导高血压大鼠肠系膜动脉PP2A激活的机制研究[J].中国病理生理杂志,2019,35(10):1729-1735.
[17] Wang NP,Erskine J,Zhang WW,et al. Recruitment of ma- crophages from the spleen contributes to myocardial fibrosis and hypertension induced by angiotensin Ⅱ [J]. J Renin Angiotensin Aldosterone Syst,2017,18(2):1606536803.
[18] 张飞飞,赵士霞,郝清卿,等.心脏收缩力调节对慢性心力衰竭兔心室肌电重构的影响[J]. 中国病理生理杂志,2020,36(3):547-551.
[19] Gaetani R,Zizzi EA,Deriu MA,et al. When Stiffness Matters:Mechanosensing in Heart Development and Disease [J]. Front Cell Dev Biol,2020,8:334.
[20] Bacmeister L,Schwarzl M,Warnke S,et al. Inflammation and fibrosis in murine models of heart failure [J]. Basic Res Cardiol,2019,114(3):19.
[21] Holjak E,Savinova I,Nelson VL,et al. An Evaluation of Cardiac Health in the Spontaneously Hypertensive Rat Colony:Implications of Evolutionary Driven Increases in Concentric Hypertrophy [J]. Am J Hypertens,2022,35(3):264-271.
[22] Liu L,Zhang D,Li Y. LncRNAs in cardiac hypertrophy:From basic science to clinical application [J]. J Cell Mol Med,2020,24(20):11638-11645.
[23] 乌日罕,哈斯高娃,陈小辛,等.类固醇激素合成急性调节蛋白(StAR)的研究进展[J].当代畜禽养殖业,2021(4):20-26.
[24] Zhao S,Sun W,Jiang P. Role of the ACE2/Ang-(1-7)/Mas axis in glucose metabolism [J]. Rev Cardiovasc Med,2021, 22(3):769-777.
[25] Galano M,Venugopal S,Papadopoulos V. Role of STAR and SCP2/SCPx in the Transport of Cholesterol and Other Lipids [J]. Int J Mol Sci,2022,23(20):12115.
[26] 周子默,周驰,杨雅元,等.心肌纤维化的发病及治疗研究进展[J].湖北科技学院学报(医学版),2022,36(5):452-456.
[27] Goumans MJ,Ten DP. TGF-beta Signaling in Control of Cardiovascular Function [J]. Cold Spring Harb Perspect Biol,2018,10(2):a22210.
[28] 李开智,杨森林,姜晖,等.依达拉奉对心肌梗死大鼠心肌细胞凋亡的抑制作用及机制研究[J].中国现代医学杂志,2020,30(1):13-20. |
|
|
|